- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- September 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 193 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- May 2024
- 128 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 128 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 138 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- September 2024
- 132 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- April 2024
- 160 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- February 2021
- 420 Pages
United States
From €2282EUR$2,400USD£1,917GBP
- Report
- December 2022
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2024
- 200 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- November 2023
- 92 Pages
China
From €1711EUR$1,800USD£1,438GBP

Olanzapine is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and depression. It is a member of the atypical antipsychotic class of drugs, which are used to treat the symptoms of mental health conditions. Olanzapine works by blocking certain receptors in the brain, which helps to reduce the symptoms of mental health conditions. It is also used to treat agitation and aggression in people with dementia.
Olanzapine is a widely used medication in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, and is often prescribed as a first-line treatment for schizophrenia. It is also used to treat other mental health conditions, such as bipolar disorder and depression. Olanzapine is generally well-tolerated, and has fewer side effects than other antipsychotic medications.
Some companies in the Olanzapine market include Eli Lilly, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more